Comparative Pharmacology
Head-to-head clinical analysis: AK FLUOR 10 versus LYMPHAZURIN.
Peer-Reviewed Evidence
Head-to-head clinical analysis: AK FLUOR 10 versus LYMPHAZURIN.
AK-FLUOR 10% vs LYMPHAZURIN
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Fluorescein sodium is a diagnostic dye that absorbs light in the blue spectrum (465-490 nm) and emits green-yellow fluorescence (520-530 nm). It is used to visualize blood flow, detect corneal abrasions, and assess vascular integrity by highlighting areas of leakage or damage.
Lymphazurin is a diagnostic dye composed of isosulfan blue. It is a hydrophilic molecule that selectively binds to serum albumin and is preferentially taken up by lymphatic vessels. When injected subcutaneously or intradermally, it enters the lymphatic system and stains the lymphatic vessels and nodes, allowing for visual identification during lymph node mapping and sentinel lymph node biopsy procedures.
Intravenous injection: 5-10 mL (500-1000 mg fluorescein sodium) given rapidly over 4-5 seconds.
0.1 mL (100 mcg) administered via submucosal injection in 3 divided doses into the distal submucosa surrounding the cervical os (12, 4, and 8 o'clock positions) at a depth of 3 mm, 10 minutes prior to the procedure.
None Documented
None Documented
Terminal elimination half-life is approximately 1-2 minutes in patients with normal renal function. This short half-life reflects rapid redistribution and renal clearance.
Terminal elimination half-life is 18–24 hours; prolonged in renal impairment (up to 40 hours in severe impairment), requiring dose adjustment.
Primarily renal (unchanged). Approximately 80-90% of an administered dose is excreted unchanged in urine within 24 hours. Biliary/fecal excretion is minimal (<5%).
Primarily renal excretion as unchanged drug (approximately 70%) and as glucuronide conjugate (20%); negligible biliary or fecal elimination (<5%).
Category C
Category C
Diagnostic Dye
Diagnostic Dye